|
Nov 1
|
Health Canada approves Ultomiris for adults with neuromyelitis optica spectrum disorder (NMOSD)
|
|
Oct 31
|
Astrazeneca (AZN) Rises But Trails Market: What Investors Should Know
|
|
Oct 3
|
The 10 pharma companies participating in Medicare price negotiations
|
|
Oct 3
|
AstraZeneca pays £350m to settle heartburn drugs lawsuits
|
|
Oct 3
|
AstraZeneca settles heartburn drug lawsuits for $425mn
|
|
Oct 3
|
UPDATE 3-AstraZeneca to pay $425 million to end US lawsuits over heartburn drugs
|
|
Oct 3
|
AstraZeneca to pay $425 million to end US lawsuits over heartburn drugs
|
|
Oct 2
|
J&J's (JNJ) Rybrevant Combo Meets Primary Goal in NSCLC Study
|
|
Oct 2
|
AstraZeneca (AZN) Key Drugs to Aid Growth, Pipeline Strong
|
|
Sep 30
|
20 Best Residency by Investment Programs in 2023
|
|
Sep 29
|
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
|
|
Sep 28
|
Astrazeneca (AZN) Stock Sinks As Market Gains: What You Should Know
|
|
Sep 28
|
UPDATE 3-J&J's lung cancer therapy succeeds in head-to-head study with AstraZeneca's drug
|
|
Aug 10
|
Ionis (IONS) Q2 Loss Narrows Y/Y, Sales Surpass Estimates
|
|
Aug 10
|
Q2 2023 Ionis Pharmaceuticals Inc Earnings Call
|
|
Aug 9
|
AstraZeneca signs vaccine deal with China’s CanSino
|
|
Aug 9
|
UPDATE 1-China's CanSino in mRNA vaccine deal with AstraZeneca
|
|
Aug 8
|
China's CanSino in mRNA vaccine deal with AstraZeneca
|
|
Aug 8
|
Is This Blue Chip Dividend Stock a Buy for Growth Investors?
|
|
Aug 4
|
CDC Recommends New Sanofi, AstraZeneca Shot to Prevent RSV in Babies
|